BIONOVA
ActiveFrom the official registers: KBO 29 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
BIONOVA has been active since 1996 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €446,286 and a net result of €57,801. Equity has been stable since 2018 (±1.8% per year). Its solvency ranks better than 30% of 317 sector peers (NACE 20, financial year 2025). The computed 12-month bankruptcy probability is 0.5% (very low).
History
Acts, filings and financial milestones
Deadline for the 2026 accounts:
2026
24-09
financial year 2025 · full format · 55 days late
2025
30-07
financial year 2024 · abbreviated format
2024
31-08
financial year 2023 · abbreviated format · 31 days late
2023
22-06
financial year 2022 · abbreviated format
2022
05-07
financial year 2021 · abbreviated format
2021
31-12
Financial
Highest result from 2018 to 2025net €97,934 ▲2.4%
The operating result of €152,574 and the net result of €97,934 are both a record.
28-06
financial year 2020 · abbreviated format
2020
10-08
financial year 2019 · abbreviated format · 10 days late
2019
31-12
Financial
Back to profitnet €14,039
The net result is €14,039, after one loss-making year.
12-07
financial year 2018 · abbreviated format
2018
31-08
financial year 2017 · abbreviated format · 31 days late
2017
28-07
financial year 2016 · abbreviated format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank